6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
18m ago	NexTel Medical Corp Enters Final Stage for Commercial Launch; Sets Sights on Revenue Generation and OTCQB Uplist
44m ago	Cantor Fitzgerald Asset Management and RPM Living Acquire Biscayne Shores, a New Waterfront Multifamily Community in North Miami
45m ago	American Battery Technology Company Announces Record Breaking Revenue and First-Ever Positive Gross Margin in Third Quarter Fiscal 2026 Financial Results
47m ago	Docusign Announces Agentic Contract Workflows for In-House Legal Teams
48m ago	SFS Holdings Corp. Terminates 10b5-1 Plan

About

Avalo Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Avalo Therapeutics Announces Pricing of $375 Million Public Offering

Avalo Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Avalo Therapeutics Purchases Optional Milestone Buyout

Avalo Therapeutics Reports 2025 Financial Results and Recent Business Updates

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Recent Videos

AVTX STOCK : FRESH BREAKOUT | AVALO THERAPEUTICS STOCK

AVTX STOCK : FRESH BREAKOUT | AVALO THERAPEUTICS STOCK

May 08, 2026

AVTX +58.6% — Positive Phase 2 Results for Abdakibart Propel Avalo Therapeutics to Phase 3

AVTX +58.6% — Positive Phase 2 Results for Abdakibart Propel Avalo Therapeutics to Phase 3

May 05, 2026

Cómo invertir en Avalo Therapeutics Inc (AVTX)

Cómo invertir en Avalo Therapeutics Inc (AVTX)

Mar 17, 2026

$2.8 Million Trade in Avalo Therapeutics (AVTX): Buy?

$2.8 Million Trade in Avalo Therapeutics (AVTX): Buy?

Feb 25, 2026

Community Chat

Ask AI